Morphological stages of pilomatricoma.

PubWeight™: 1.35‹?› | Rank: Top 10%

🔗 View Article (PMID 8879294)

Published in Am J Dermatopathol on August 01, 1996

Authors

S Kaddu1, H P Soyer, S Hödl, H Kerl

Author Affiliations

1: Department of Dermatology, University of Graz, Austria.

Articles by these authors

Tutorial on melanocytic lesions. Am J Dermatopathol (2001) 2.99

EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood (1997) 2.85

Dermoscopy of Bowen's disease. Br J Dermatol (2004) 2.34

Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimens. Arch Dermatol (2002) 2.07

Internet-based program for automatic discrimination of dermoscopic images between melanomas and Clark naevi. Br J Dermatol (2004) 1.99

Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol (2007) 1.89

Adjuvant interferon alfa-2a treatment in resected primary stage II cutaneous melanoma. Austrian Malignant Melanoma Cooperative Group. J Clin Oncol (1998) 1.82

Mobile teledermatology for skin tumour screening: diagnostic accuracy of clinical and dermoscopic image tele-evaluation using cellular phones. Br J Dermatol (2011) 1.78

Epidermotropic metastatic malignant melanoma simulating melanoma in situ. A report of 10 examples from two patients. Am J Surg Pathol (1994) 1.69

Reticulohistiocytoma and multicentric reticulohistiocytosis. Histopathologic and immunophenotypic distinct entities. Am J Dermatopathol (1994) 1.66

Granulomatous cheilitis and Borrelia burgdorferi: polymerase chain reaction and serologic studies in a retrospective case series of 12 patients. Arch Dermatol (2000) 1.65

Extramedullary hematopoiesis in pilomatricomas. Am J Dermatopathol (1995) 1.61

A double-blind, controlled clinical trial of homeopathy and an analysis of lunar phases and postoperative outcome. Arch Dermatol (1998) 1.61

Strategies for assessing the degree of photodamage to skin: a systematic review of the literature. Br J Dermatol (2011) 1.57

Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol (1997) 1.53

Cutaneous spindle-cell B-cell lymphoma: a morphologic variant of cutaneous large B-cell lymphoma. Am J Dermatopathol (2000) 1.52

Laypersons' sensitivity for melanoma identification is higher with dermoscopy images than clinical photographs. Br J Dermatol (2012) 1.51

Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria. J Am Acad Dermatol (1999) 1.50

Dermoscopic classification of atypical melanocytic nevi (Clark nevi). Arch Dermatol (2001) 1.49

Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol (1994) 1.47

Photopheresis for renal allograft rejection. Lancet (1995) 1.47

Teledermatology for skin cancer prevention: an experience on 690 Austrian patients. J Eur Acad Dermatol Venereol (2013) 1.46

Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept. Br J Dermatol (2008) 1.46

Personal digital assistants in teledermatology. Br J Dermatol (2006) 1.44

Cutaneous leiomyosarcoma. Am J Surg Pathol (1997) 1.44

Acral pseudolymphomatous angiokeratoma. A variant of the cutaneous pseudolymphomas. Am J Dermatopathol (1994) 1.41

A pilot trial of mobile, patient-performed teledermoscopy. Br J Dermatol (2015) 1.39

Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light. Arch Dermatol (1997) 1.38

Amelanotic/Hypomelanotic melanoma--is dermatoscopy useful for diagnosis? J Dtsch Dermatol Ges (2003) 1.38

Leukemic cells within skin lesions of psoriasis in a patient with acute myelogenous leukemia. J Cutan Pathol (1997) 1.38

Does surgical removal of primary melanoma trigger growth of occult metastases? An analytical epidemiological approach. Dermatol Surg (1997) 1.36

Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol (1994) 1.31

Dermoscopy of pigmented skin lesions--a valuable tool for early diagnosis of melanoma. Lancet Oncol (2001) 1.28

Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study. Br J Dermatol (2004) 1.27

Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? J Am Acad Dermatol (1993) 1.22

Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol (2007) 1.21

Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans. J Invest Dermatol (2000) 1.20

Feasibility and acceptance of telemedicine for wound care in patients with chronic leg ulcers. J Telemed Telecare (2006) 1.17

Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma. Adv Anat Pathol (1998) 1.17

The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality. Br J Dermatol (2008) 1.17

Detection of Borrelia burgdorferi-specific DNA in urine specimens from patients with erythema migrans before and after antibiotic therapy. J Clin Microbiol (1996) 1.14

Foreign body granulomas due to injectable aesthetic microimplants. Am J Surg Pathol (1999) 1.14

Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features. Br J Dermatol (2004) 1.11

Face-to-face diagnosis vs telediagnosis of pigmented skin tumors: a teledermoscopic study. Arch Dermatol (1999) 1.11

Pathology and pathobiology of actinic (solar) keratosis - an update. Br J Dermatol (2007) 1.11

Proposal of a new classification system for melanocytic naevi. Br J Dermatol (2007) 1.10

Auriculotemporal (Frey) syndrome in late childhood: an unusual variant presenting as gustatory flushing mimicking food allergy. Pediatr Dermatol (2000) 1.07

Proliferating pilomatricoma. A histopathologic simulator of matrical carcinoma. J Cutan Pathol (1997) 1.05

[ Pilar sheath acanthoma - a benign follicular hamartoma]. Dermatologica (1983) 1.05

Three-point checklist of dermoscopy: an open internet study. Br J Dermatol (2006) 1.04

Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia: a clinicopathologic and prognostic study of 42 patients. Am J Surg Pathol (1996) 1.04

Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis. Melanoma Res (2002) 1.01

Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol (1997) 1.01

Teledermoscopy--results of a multicentre study on 43 pigmented skin lesions. J Telemed Telecare (2000) 1.01

Different treatment modalities for the management of a patient with the nevoid basal cell carcinoma syndrome. J Am Acad Dermatol (1996) 1.00

Pustulosis acuta generalisata is a post-streptococcal disease and is distinct from acute generalized exanthematous pustulosis. Br J Dermatol (1995) 1.00

Giant eccrine acrospiroma. J Am Acad Dermatol (1990) 0.99

Surgical treatment of dermatofibrosarcoma protuberans. A retrospective study of 20 cases with review of literature. Eur J Surg Oncol (1991) 0.98

Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol (1999) 0.98

Annular elastolytic giant cell granuloma: sparing of a burn scar and successful treatment with chloroquine. Br J Dermatol (1999) 0.98

Expression of the homeobox gene HOXC4 in keratinocytes of normal skin and epithelial skin tumors is correlated with differentiation. J Invest Dermatol (1994) 0.98

Polymorphic eruption of pregnancy: clinicopathology and potential trigger factors in 181 patients. Br J Dermatol (2006) 0.97

New immunocytochemical observations with diagnostic significance in cutaneous neuroendocrine carcinoma. Am J Dermatopathol (1984) 0.97

CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds. J Invest Dermatol (1998) 0.96

Primary cutaneous Hodgkin's disease. Unique clinical, morphologic, and immunophenotypic findings. Am J Dermatopathol (1994) 0.96

[Sclerosing lipogranuloma (paraffin-induced granuloma) of the penis with a clinical picture of carcinoma]. Hautarzt (1988) 0.96

Modelling melanoma in mice. Pigment Cell Melanoma Res (2011) 0.96

Sensitivity in the clinical diagnosis of malignant melanoma. Melanoma Res (1998) 0.96

Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome. Antimicrob Agents Chemother (2003) 0.95

T1796A BRAF mutation is absent in Merkel cell carcinoma. Br J Dermatol (2005) 0.95

The additive value of second opinion teleconsulting in the management of patients with challenging inflammatory, neoplastic skin diseases: a best practice model in dermatology? J Eur Acad Dermatol Venereol (2007) 0.95

Rudimentary meningocele: remnant of a neural tube defect? Arch Dermatol (2001) 0.94

CD56+ blastic transformation of chronic myeloid leukemia involving the skin. J Cutan Pathol (1999) 0.93

[Side-effects of beta-receptor blockaders on the skin]. Z Hautkr (1983) 0.93